Citigroup projects Bitcoin could reach $143,000 in 12 months (62% upside from $87,000) with a bull case of $189,000 and bear case of $78,500. Citi’s base case expects $15 billion in spot Bitcoin ETF ...
Federal Reserve Bank of Cleveland President Beth Hammack said monetary policy is in a good place to pause and assess the effects of 75 basis points of rate cuts in the economy during the first quarter ...
Federal Reserve Bank of Cleveland President Beth Hammack said monetary policy is in a good place to pause and assess the effects of 75 basis points of rate cuts in the economy during the first quarter ...
Amid the recent bearish price action, the headline on Citigroup's 12-month outlook for bitcoin BTC $89,275.90 of $143,000 — or about 62% upside from the current $88,000 — will raise some eyebrows. “We ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best NASDAQ stocks under $10 to buy. As of December 15, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) has a ‘Hold’ or equivalent rating from ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
A call to safeguard children is a common theme among some Republicans, connecting issues like abortion, immigration, and transgender rights. The U.S. House voted nearly unanimously to order the ...
U.S. Treasury yields firmed into the end of the week as the market slowly stepped away from the defensive positioning seen during the government shutdown. The resolution of the 43-day closure removed ...
Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...
OPEC+ is currently expected to focus on reviving another modest sliver of oil production in December as a base case when key members meet this weekend, according to two delegates. The group led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results